Details for Patent: 6,288,082
✉ Email this page to a colleague
Summary for Patent: 6,288,082
| Title: | Substituted 3-cyanoquinolines |
| Abstract: | This invention provides compounds of formula I having the structurewherein G1, G2, R1, R4, Z, n, and X are defined in the specification or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of polycystic kidney disease. |
| Inventor(s): | Allan Wissner, Hwei-Ru Tsou, Dan M. Berger, Middleton B. Floyd, Jr., Philip R. Hamann, Nan Zhang, Mark E. Salvati, Philip Frost |
| Assignee: | Wyeth Holdings LLC |
| Application Number: | US09/406,573 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 6,288,082
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
